Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

BACKGROUND: Subtypes defined by hormonal receptor (HR) and HER2 status have not been well studied in inflammatory breast cancer (IBC). We characterized clinical parameters and long-term outcomes, and compared pathological complete response (pCR) rates by HR/HER2 subtype in a large IBC patient popula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Masuda, H., Brewer, T. M., Liu, D. D., Iwamoto, T., Shen, Y., Hsu, L., Willey, J. S., Gonzalez-Angulo, A. M., Chavez-MacGregor, M., Fouad, T. M., Woodward, W. A., Reuben, J. M., Valero, V., Alvarez, R. H., Hortobagyi, G. N., Ueno, N. T.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2014
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905780/
https://ncbi.nlm.nih.gov/pubmed/24351399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt525
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge